Arthritis & Rheumatology News and Research

Latest Arthritis & Rheumatology News and Research

High-resolution TB-PET/CT scanner reveals complete picture of systemic inflammatory arthritis

For the first time, physicians can examine the systemic burden of inflammatory arthritis simultaneously across all joints and organ systems, using the high-sensitivity, high-resolution uEXPLORER total-body positron emission tomography/computed tomography (TB-PET/CT) scanner.

13 Jul 2020

New opioid medication may slow the progression of osteoarthritis

A novel preclinical study by Keck Medicine of USC researchers, published in Arthritis & Rheumatology, reveals that a potential new opioid medication may have the ability to slow the progression of osteoarthritis while being less addictive than commonly prescribed opioid drugs.

13 Jul 2020

Study shows smoking is associated with a higher likelihood of COVID-19 progression

As the number of young adults infected with the coronavirus surges throughout the nation, a new study by researchers at UCSF Benioff Children's Hospitals indicates that youth may not shield people from serious disease.

13 Jul 2020

Newly identified gene variants in Black Americans could lead to precision prostate cancer therapies

Black men in the United States are known to suffer disproportionately from prostate cancer, but few studies have investigated whether genetic differences in prostate tumors could have anything to do with these health disparities.

11 Jul 2020

New clinical trial to assess safety and efficacy of convalescent plasma to prevent COVID-19

There is only one approved, specific treatment for COVID-19, the illness caused by the novel coronavirus SARS-CoV-2, albeit with modest efficacy.

10 Jul 2020

Salmonella biofilm protein can cause autoimmune responses, arthritis in animals

Scientists from the Vaccine and Infectious Disease Organization-International Vaccine Centre at the University of Saskatchewan and Temple University have demonstrated that a Salmonella biofilm protein can cause autoimmune responses and arthritis in animals.

10 Jul 2020

People with arthritis report worsening symptoms during Covid-19 lockdown

People with arthritis experienced a ‘roller coaster’ of emotions and saw their symptoms worsen during the Covid-19 lockdown – according to research from the University of East Anglia.

9 Jul 2020

Workers in certain jobs face increased risk of developing knee osteoarthritis

Workers in jobs that typically involve heavy lifting, frequent climbing, prolonged kneeling, squatting, and standing face an increased risk of developing knee osteoarthritis.

8 Jul 2020

QUT and Oxford collaborate on clinical trial to test asthma inhalers as treatment for COVID-19

QUT researchers are collaborating with colleagues at the University of Oxford on a UK clinical trial to test common asthma inhalers as a treatment for COVID-19 infection.

8 Jul 2020

Methotrexate is not an additional risk factor for interstitial lung disease in RA patients

Patients with rheumatoid arthritis (RA) often suffer from what is referred to as interstitial lung disease (ILD).

7 Jul 2020

National Psoriasis Foundation announces $3.28 million in research grants and fellowships

The National Psoriasis Foundation, NPF, is proud to announce the awarding of $3.28 million in research grants and fellowships in 2020.

6 Jul 2020

2021 health plans granted leeway to limit consumers’ benefit from drug coupons

Without medication to manage her plaque psoriasis, Jennifer Brown's face, scalp, trunk and neck periodically become covered in painful red, flaky patches so dry they crack and bleed.

6 Jul 2020

Latest findings put Benson Viscometers at the forefront of Covid-19 fight

A clinical viscosity diagnostic instrument is proving to be valuable in the research and treatment of coronavirus after laboratory scientists have identified its ability to provide meaningful data for medical teams treating Covid-19 patients.

3 Jul 2020

New drug discovery shows promise in fighting acute respiratory illnesses

A collaboration between the University of Toronto's Faculty of Dentistry and the National Jewish Health in Denver -- the top-ranked respiratory research hospital in the U.S. -- has yielded a new drug discovery that could be useful to combat inflammation of all varieties and shows promise in fighting acute respiratory illnesses such as COVID-19.

2 Jul 2020

Repurposed drug for acute lung injury in COVID-19

Now, a new study addresses the possible use of an FDA-approved monoclonal antibody, called fostamatinib, a spleen tyrosine kinase inhibitor (SYK), to reduce the levels of mucin-1, a molecule associated with acute lung injury and acute respiratory distress syndrome (ARDS). People who have severe COVID-19 disease may develop ARDS.

2 Jul 2020

Study reveals the role of glucocorticoid metabolism and GILZ regulation during aging

Why do we age? What exactly is happening in our bodies? And can we do anything about it? Mankind has sought answers to these questions since time immemorial.

1 Jul 2020

Alternative antibiotics for unverified penicillin allergies likely unnecessary

Hospitalized patients who report an allergy to penicillin are often prescribed alternative antibiotics for infection that can be harmful, even though diagnostic testing or evaluations would show that the vast majority of these reported allergies could be disproven, according to researchers from Massachusetts General Hospital.

30 Jun 2020

ACR releases position statement supporting the role of telemedicine in rheumatology

The American College of Rheumatology (ACR) has released an official position statement supporting the role of telemedicine as a tool with the potential to increase access and improve care for patients with rheumatic diseases.

29 Jun 2020

Study identifies new allergy pathway

Researchers at Johns Hopkins Bloomberg School of Public Health have identified the sequence of molecular events by which tiny, tick-like creatures called house dust mites trigger asthma and allergic rhinitis.

25 Jun 2020

Biological therapy may decrease the risk of severe COVID-19

A recent observational study by Spanish researchers, currently available on the medRxiv preprint server, suggests that patients with immune-mediated diseases who receive biological therapy may have a lower risk for severe manifestations of coronavirus disease (COVID-19).

25 Jun 2020

Arthritis & Rheumatology News and Research

Latest Arthritis & Rheumatology News and Research

High-resolution TB-PET/CT scanner reveals complete picture of systemic inflammatory arthritis

New opioid medication may slow the progression of osteoarthritis

Study shows smoking is associated with a higher likelihood of COVID-19 progression

Newly identified gene variants in Black Americans could lead to precision prostate cancer therapies

New clinical trial to assess safety and efficacy of convalescent plasma to prevent COVID-19

Salmonella biofilm protein can cause autoimmune responses, arthritis in animals

People with arthritis report worsening symptoms during Covid-19 lockdown

Workers in certain jobs face increased risk of developing knee osteoarthritis

QUT and Oxford collaborate on clinical trial to test asthma inhalers as treatment for COVID-19

Methotrexate is not an additional risk factor for interstitial lung disease in RA patients

National Psoriasis Foundation announces $3.28 million in research grants and fellowships

2021 health plans granted leeway to limit consumers’ benefit from drug coupons

Latest findings put Benson Viscometers at the forefront of Covid-19 fight

New drug discovery shows promise in fighting acute respiratory illnesses

Repurposed drug for acute lung injury in COVID-19

Study reveals the role of glucocorticoid metabolism and GILZ regulation during aging

Alternative antibiotics for unverified penicillin allergies likely unnecessary

ACR releases position statement supporting the role of telemedicine in rheumatology

Study identifies new allergy pathway

Biological therapy may decrease the risk of severe COVID-19

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Arthritis & Rheumatology News and Research

Latest Arthritis & Rheumatology News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in